- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Low or intermediate risk prostate cancer
Total 264146 results
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, France, United States, Australia, Brazil, Germany, Taiwan, Denmark, China, Japan, Canada, Finland, Italy, Hungary, Portugal, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia, Netherlands
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Xian-Janssen Pharmaceutical Ltd.Not yet recruitingProstate Cancer | Biochemical Recurrence | High RiskChina
-
ElsanRecruitingPatients With Suspected Prostate CancerFrance
-
Chinese University of Hong KongRecruiting
-
Case Comprehensive Cancer CenterRecruitingPancreatic FistulaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbRecruitingMyelodysplastic Syndromes | Anemia | Myeloproliferative NeoplasmUnited States
-
National Taiwan University HospitalRecruitingPre-fibrotic MyelofibrosisTaiwan
-
University of ChicagoRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
University of ChicagoRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate NeoplasmUnited States
-
NRG OncologyNational Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eastern... and other collaboratorsRecruitingHER2-positive Breast CancerUnited States, Puerto Rico
-
West German Study GroupAstraZenecaNot yet recruitingHER2-positive Early Breast CancerGermany
-
Urological Research Network, LLCRecruitingMRI | Urinary Incontinence | Prostate Cancer | Ultrasound | Ablation | Sexual Function Disturbances | Prostate Biopsy | Adverse Effects Surgery | Urinary Function DisordersUnited States
-
Heinrich-Heine University, DuesseldorfGerman Cancer AidNot yet recruitingProstate Cancer | Familial Prostate Cancer
-
AstraZenecaNot yet recruiting
-
Istituto Clinico HumanitasMediolanum Cardio ResearchRecruiting
-
Al-Azhar UniversityRecruiting
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Australia, Spain, United Kingdom, Canada, Brazil, Mexico, Germany, Ireland, South Africa, France, Israel, Georgia, Turkey, Italy, Poland, Chile, Argentina, Belgium, Czechia, Romania, Greece
-
University of ChicagoRecruitingProstate Cancer ScreeningUnited States
-
University College, LondonNational Institute for Health Research, United KingdomRecruitingDifferentiated Thyroid CancerUnited Kingdom
-
Shaare Zedek Medical CenterRecruiting
-
European Institute of OncologyRecruitingProstate Cancer | Positron Emission Tomography | PSMAItaly
-
VA Office of Research and DevelopmentRecruiting
-
Case Comprehensive Cancer CenterNot yet recruiting
-
Weill Medical College of Cornell UniversityRecruitingGynecologic Cancer | Hereditary Cancer SyndromeUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingHigh-risk Prostate CancerFrance
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
Société Internationale d'UrologieRecruitingLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaCanada, Italy, United Kingdom, Cyprus, United States, Chile
-
American College of RadiologyRTOG Foundation, Inc.RecruitingHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the OropharynxUnited States
-
Syed Ali ImranNot yet recruitingLow Risk Differentiated Thyroid Cancer
-
M.D. Anderson Cancer CenterAmerican Cancer Society, Inc.Recruiting
-
Royal Marsden NHS Foundation TrustRecruiting
-
UNC Lineberger Comprehensive Cancer CenterRecruitingQuality of Life | Breast CancerUnited States
-
University of California, San DiegoRecruitingProstate CancerUnited States
-
Sumitomo Pharma Switzerland GmbHRecruitingProstate CancerUnited States
-
Sven LöffelerOslo University Hospital; KlinbeforskRecruitingProstate CancerNorway, Denmark, Finland
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingProstate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
West China HospitalRecruitingProstate Cancer | Efficacy | Safety | Stereotactic Body Radiotherapy | High-riskChina
-
Stanford UniversityRecruiting
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNeoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine TherapyChina
-
Northwell HealthRecruitingProstate Cancer | Magnetic Resonance Imaging | Population at RiskUnited States
-
Hongqian GuoFirst Affiliated Hospital of Zhejiang University; Nanjing First Hospital, Nanjing... and other collaboratorsRecruitingNeoadjuvant TherapyChina
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndromes | Myeloproliferative Chronic Myelomonocytic LeukemiaUnited States
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsRecruitingProstate Cancer | Radiotherapy Side EffectDenmark
-
BayerRecruitingNon-metastatic Castration-resistant Prostate CancerIndia
-
Cancer Institute and Hospital, Chinese Academy...Beijing Huanxing Cancer Hospital; Cancer Hospital, Chinese Academy of Medical...RecruitingEarly-stage Breast CancerChina
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceNot yet recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Melanoma | Sarcoma | Acute Myeloid Leukemia | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Stage III Pancreatic... and other conditionsUnited States
-
Miquel Angel Pavon RibasCatalan Institute of Health; Hospital del MarRecruitingCervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III) | Human Papillomavirus (HPV) Infections | High-risk HPV | HPV-16/ 18Spain
-
University Health Network, TorontoRecruiting